DS enhances the osteogenic potential of PDLSCs in association with the activation of mitophagy-related processes. It mitigates inflammation-impaired osteogenesis, potentially via modulation of the RIG-I-mediated RLR signaling pathway, in association with increased mitophagy-related activity. DS represents a potent therapeutic small molecule for ameliorating periodontitis-induced bone loss.
Building similarity graph...
Analyzing shared references across papers
Loading...
Stem Cell Research & Therapy
Beijing University of Chinese Medicine
Zunyi Medical University
Longgang Central Hospital
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
He et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: